Cytomegalovirus ileitis in a patient after liver transplantation-differentiating from de novo IBD

Journal of Crohn's and Colitis

Volumn 5, Issue 4, 2011, Pages 354-359

  Navaneethan, Udayakumar ^a,b   Venkatesh, Preethi G K ^b   Wang, Jiang ^a,b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Cytomegalovirus; Ileitis; Inflammatory bowel disease; Liver transplantation

Indexed keywords

FOSCARNET; GANCICLOVIR; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID; STEROID; TACROLIMUS; VALACICLOVIR;

ADULT; ANTIVIRAL THERAPY; ARTICLE; CASE REPORT; CELL COMPARTMENTALIZATION; CLINICAL ARTICLE; COLONOSCOPY; CYTOMEGALOVIRUS INFECTION; DIFFERENTIAL DIAGNOSIS; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ENTERITIS; FIBROSIS; FOLLOW UP; GASTROINTESTINAL TRACT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; ILEITIS; ILEUM; IMMUNE DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; INTESTINE STENOSIS; LIVER TRANSPLANTATION; MALE; NUTRITIONAL STATUS; PRIORITY JOURNAL; SMALL INTESTINE OBSTRUCTION; TOTAL PARENTERAL NUTRITION; TREATMENT DURATION; ULCER;

ADULT; CYTOMEGALOVIRUS INFECTIONS; DIAGNOSIS, DIFFERENTIAL; HUMANS; ILEITIS; IMMUNOSUPPRESSION; INFLAMMATORY BOWEL DISEASES; LIVER TRANSPLANTATION; MALE; POSTOPERATIVE COMPLICATIONS;

EID: 79958852932     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1016/j.crohns.2011.01.010     Document Type: Article

References (31)

1. Department of Health and Human Services Centers for Disease Control and Prevention Available from: URL:, Last Modified: November 3. http://http:www.cdc.gov/cmv/facts.htm.
2. Razonable R.R., Emery V.C. Management of CMV infection and disease in transplant patients. 27-29 February 2004. Herpes 2004, 11:77-86.
3. Razonable R.R., Paya C.V. Herpesvirus infections in transplant recipients: current challenges in the clinical management of cytomegalovirus and Epstein-Barr virus infections. Herpes 2003, 10:60-65.
4. Baroco A.L., Oldfield E.C. Gastrointestinal cytomegalovirus disease in the immunocompromised patient. Curr Gastroenterol Rep 2008, 10:409-416.
5. Paya C., Razonable R.R. Cytomegalovirus infection after solid organ transplantation. Transplant infections 2003, Vol 1:298-325. Lippincott, Williams and Wilkins, Philadelphia, PA.
6. Gane E., Saliba F., Valdecasas G.J., O'Grady J., Pescovitz M.D., Lyman S., et al. Randomised trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver-transplant recipients. The Oral Ganciclovir International Transplantation Study Group [corrected]. Lancet 1997, 350:1729-1733.
7. Razonable R.R., van Cruijsen H., Brown R.A., Wilson J.A., Harmsen W.S., Wiesner R.H., et al. Dynamics of cytomegalovirus replication during preemptive therapy with oral ganciclovir. J Infect Dis 2003, 187:1801-1808.
8. Singh N., Wannstedt C., Keyes L., Wagener M.M., Cacciarelli T.V. Who among cytomegalovirus-seropositive liver transplant recipients is at risk for cytomegalovirus infection?. Liver Transpl 2005, 11:700-704.
9. Arthurs S.K., Eid A.J., Pedersen R.A., Dierkhising R.A., Kremers W.K., Patel R., et al. Delayed-onset primary cytomegalovirus disease after liver transplantation. Liver Transpl 2007, 13:1703-1709.
10. Chamberlain R.S., Atkins S., Saini N., White J.C. Ileal perforation caused by cytomegalovirus infection in a critically ill adult. J Clin Gastroenterol 2000, 30:432-435.
11. Khan F.N., Prasad V., Klein M.D. Cytomegalovirus enteritis mimicking Crohn's disease in a lupus nephritis patient: a case report. World J Gastroenterol 2009 Sep 14, 15(34):4327-4330.
12. Fica A., Cervera C., Perez N., Marcos M.A., Ramírez J., Linares L., et al. Immunohistochemically proven cytomegalovirus end-organ disease in solid organ transplant patients: clinical features and usefulness of conventional diagnostic tests. Transpl Infect Dis 2007, 9:203-210.
13. Shimizu T., Marusawa H., Yamashita Y. Diaphragm-like stricture of the small intestine related to cytomegalovirus infection. Clin Gastroenterol Hepatol. 2010 Feb 1, [Epub ahead of print].
14. Limaye A.P. Ganciclovir-resistant cytomegalovirus in organ transplant recipients. Clin Infect Dis 2002, 35:866-872.
15. Limaye A.P. Antiviral resistance in cytomegalovirus: an emerging problem in organ transplant recipients. Semin Respir Infect 2002, 17:265-273.
16. Goodgame R.W. Gastrointestinal cytomegalovirus disease. Ann Intern Med 1993, 119:924-935.
17. Ljungman P., Griffiths P., Paya C. Definitions of cytomegalovirus infection and disease in transplant recipients. Clin Infect Dis 2002, 34:1094-1097.
18. Paya C.V., Hermans P.E., Wiesner R.H., Ludwig J., Smith T.F., Rakela J., et al. Cytomegalovirus hepatitis in liver transplantation: prospective analysis of 93 consecutive orthotopic liver transplantations. J Infect Dis 1989, 160:752-758.
19. Buckner F.S., Pomeroy C. Cytomegalovirus disease of the gastrointestinal tract in patients without AIDS. Clin Infect Dis 1993, 17:644-656.
20. Reed E.C., Wolford J.L., Kopecky K.J., Lilleby K.E., Dandliker P.S., Todaro J.L., et al. Ganciclovir for the treatment of cytomegalovirus gastroenteritis in bone marrow transplant patients. A randomized, placebo-controlled trial. Ann Intern Med 1990, 112:505-510.
21. Chang H.R., Lian J.D., Chan C.H., Wong L.C. Cytomegalovirus ischemic colitis of a diabetic renal transplant recipient. ClinTransplant 2004, 18:100-104.
22. Muldoon J., O'Riordan K., Rao S., Abecassis M. Ischemic colitis secondary to venous thrombosis. A rare presentation of cytomegalovirus vasculitis following renal transplantation. Transplantation 1996, 61:1651-1653.
23. Hinnant K.L., Rotterdam H.Z., Bell E.T., Tapper M.L. Cytomegalovirus infection of the alimentary tract: a clinicopathological correlation. Am J Gastroenterol 1986, 81:944-950.
24. Lladó L., Castellote J., Fabregat J., et al. Antral mass due to cytomegalovirus infection requiring gastrectomy in a liver transplant recipient. Transpl Infect Dis 2008, 10(5):354-357.
25. Sinzger C., Grefte A., Plachter B., Gouw A.S.H., The T.H., Jahn G. Fibroblasts, epithelial cells and smooth muscle cells are major targets of human cytomegalovirus infection in lungs and gastrointestinal tissues. J GenVirol 1995, 76:741-750.
26. Burak K.W., Kremers W.K., Batts K.P., Wiesner R.H., Rosen C.B., Razonable R.R., et al. Impact of cytomegalovirus infection, year of transplantation, and donor age on outcomes after liver transplantation for hepatitis C. Liver Transpl 2002, 8:362-369.
27. Sarmiento J.M., Dockrell D.H., Schwab T.R., Munn S.R., Paya C.V. Mycophenolate mofetil increases cytomegalovirus invasive organ disease in renal transplant patients. Clin Transplant 2000, 14:136-138.
28. Eid A.J., Razonable R.R. Cytomegalovirus disease in solid organ transplant recipients: advances lead to new challenges and opportunities. Curr Opin Organ Transplant 2007, 12:610-617.
29. Razonable R.R. Cytomegalovirus infection after liver transplantation: current concepts and challenges. World J Gastroenterol 2008, 14:4849-4860.
30. Hampton D.D., Poleski M.H., Onken J.E. Inflammatory bowel disease following solid organ transplantation. Clin Immunol 2008, 128:287-293.
31. Barritt A.S., Zacks S.L., Rubinas T.C., Herfarth H.H. Oral budesonide for the therapy of post-liver transplant de novo inflammatory bowel disease: a case series and systematic review of the literature. Inflamm Bowel Dis 2008, 14:1695-1700.